Search Results 81-90 of 373 for ⚕블루벳 【룰라보증.com / 가입코드 9000】 카림벳⚕

  1. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population.

  2. Sangre por Salud Biobank - Mayo Clinic

    One 4.5-mL, light-blue-top tube. This tube contains sodium citrate. Data collected. The biobank collects these types of data: Clinical lab measurements ...

  3. A Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Platinum-Refractory Metastatic Bladder Cancer - Mayo Clinic

    The purpose of this study is to evaluate the effect of combining ACP-196 and Pembrolizumab in subjects with platinum resistant metastatic bladder cancer.

  4. Drugs and Supplements that Start with D - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “D” to learn about drug side effects, proper use and ...

  5. Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Drugs and Supplements that Start with I - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “I” to learn about drug side effects, proper use and ...

  8. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

    Lenalidomide may stop the growth of mantle cell lymphoma by blocking blood flow to the cancer. It is not yet known whether giving rituximab together with ...

  9. DefenCath in Reducing Central Line-associated Bloodstream Infections (CLABSIs) in Adult Participants Receiving Total Parenteral Nutrition (TPN) - Mayo Clinic

    The purpose of this study is evaluate the efficacy of DefenCath in reducing the incidence of CLABSI over 12 months compared with heparin as a catheter lock ...

  10. Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

    About this study. This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint ...